Abstract
Vulvar cancer is an uncommon gynecological malignancy primarily affecting postmenopausal women and is the fourth most common gynecologic cancer. There is no specific screening and the most effective strategy to reduce vulvar cancer incidence is the opportune treatment of predisposing and preneoplastic lesions associated with its development. Vulvar carcinoma can be HPV-positive or HPV- negative. Any suspicious vulvar lesion should be biopsied to exclude invasion.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of the Academy of Romanian Scientists Series of Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
